Chemoprevention of breast cancer by dietary compounds

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 10, 2012, Pages 1185-1202

  Vadodkar, Aditi S ^a   Suman, Suman ^a   Lakshmanaswamy, Rajkumar ^a   Damodaran, Chendil ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

Anti cancer; Apoptosis; Dietary agents; Metastasis; Molecular signaling

Indexed keywords

APIGENIN; BETA CAROTENE; CAROTENOID; COUMARIN DERIVATIVE; CURCUMIN; DELPHINIDIN; DITERPENOID; EMODIN; GENISTEIN; GINGEROL; ISOTHIOCYANIC ACID DERIVATIVE; KAEMPFEROL; LIGNAN; LYCOPENE; MALVIDIN CHLORIDE; NARINGENIN; PLANT MEDICINAL PRODUCT; PROANTHOCYANIDIN; QUERCETIN; SESQUITERPENE; SILIBININ; TANGERETIN; TANNIN; TRITERPENOID; UNINDEXED DRUG; WITHAFERIN A; XANTHOPHYLL; ZEAXANTHIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL SURVIVAL; CHEMOPROPHYLAXIS; DRUG MECHANISM; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC);

ANIMALS; BIOLOGICAL AGENTS; BREAST NEOPLASMS; CHEMOPREVENTION; DIET; FEMALE; FRUIT; HUMANS; VEGETABLES;

EID: 84870184167     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012803833008     Document Type: Article

References (265)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin., 2011, 61 (2), 69-90.
2. Desantis, C.; Siegel, R.; Bandi, P.; Jemal, A. Breast cancer statistics, 2011. CA Cancer J. Clin., 2011,
3. DeSantis, C.; Howlader, N.; Cronin, K. A.; Jemal, A. Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol. Biomarkers Prev., 2011, 20 (5), 733-739.
4. Amin, A. R.; Kucuk, O.; Khuri, F. R.; Shin, D. M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol., 2009, 27 (16), 2712-2725.
5. Chen, D.; Dou, Q. P. Tea polyphenols and their roles in cancer prevention and chemotherapy. Int. J. Mol. Sc., 2008, 9 (7), 1196-1206.
6. Mondal, S.; Bandyopadhyay, S.; Ghosh, M. K.; Mukhopadhyay, S.; Roy, S.; Mandal, C. Natural Products: Promising Resources For Cancer Drug Discovery. Anticancer Agents Med. Chem., 2012, 12 (1), 49-75.
7. N, S. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J. Enzyme Inhib. Med. Chem., 2011, (00), 1-27.
8. Nishino, H.; Nishino, H.; Tokuda, H.; Satomi, Y.; Masuda, M.; Onozuka, M.; Yamaguchi, S.; Takayasu, J.; Tsuruta, J.; Takemura, M.; Ii, T.; Ichiishi, E.; Kuchide, S. Okuda, M.; Murakoshi, M. Cancer chemoprevention by phytochemicals and their related compounds. Asian Pac. J. Cancer Prev., 2000, 1 (1), 49-55.
9. Ullah, M. F.; Ahmad, A.; Zubair, H.; Khan, H. Y.; Wang, Z.; Sarkar, F. H.; Hadi, S. M. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res., 2011, 55 (4), 553-559.
10. Nigam, N.; George, J.; Srivastava, S.; Roy, P.; Bhui, K.; Singh, M.; Shukla, Y. Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis. Cancer Chemother. Pharmacol., 2010, 65 (4), 687-696.
11. Surh, Y. J.; Chun, K. S. Cancer chemopreventive effects of curcumin. Adv. Exp. Med. Biol., 2007, 595, 149-172.
12. Shu, L.; Cheung, K. L.; Khor, T. O.; Chen, C.; Kong, A. N. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev., 2010, 29 (3), 483-502.
13. Rock, C. L. Carotenoids: biology and treatment. Pharmacol. Ther., 1997, 75 (3), 185-197.
14. Wyss, A. Carotene oxygenases: a new family of double bond cleavage enzymes. J. Nutr., 2004, 134 (1), 246S-250S.
15. Nagao, A. Oxidative conversion of carotenoids to retinoids and other products. J. Nutr., 2004, 134 (1), 237S-240S.
16. Cui, Y.; Lu, Z.; Bai, L.; Shi, Z.; Zhao, W. E.; Zhao, B. beta-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells. Eur. J. Cancer., 2007, 43 (17), 2590-2601.
17. Tibaduiza, E. C.; Fleet, J. C.; Russell, R. M.; Krinsky, N. I. Excentric cleavage products of beta-carotene inhibit estrogen receptor positive and negative breast tumor cell growth in vitro and inhibit activator protein-1-mediated transcriptional activation. J. Nutr., 2002, 132 (6), 1368-1375.
18. Hirsch, K.; Atzmon, A.; Danilenko, M.; Levy, J.; Sharoni, Y. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells. Breast Cancer Res. Treat., 2007, 104 (2), 221-230.
19. Prakash, P.; Russell, R. M.; Krinsky, N. I. In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J. Nutr., 2001, 131 (5), 1574-1580.
20. Bendich, A. Carotenoids and the immune response. J. Nutr.,1989, 119 (1), 112-115.
21. Krinsky, N. I. Antioxidant functions of carotenoids. Free Radic. Biol. Med., 1989, 7 (6), 617-635.
22. Shultz, T. D.; Chew, B. P.; Seaman, W. R.; Luedecke, L. O. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett., 1992, 63 (2), 125-133.
23. Burton, G. W.; Ingold, K. U. beta-Carotene: an unusual type of lipid antioxidant. Science., 1984, 224 (4649), 569-573.
24. Krinsky, N. I. The antioxidant and biological properties of the carotenoids. Ann. N. Y. Acad. Sci., 1998, 854, 443-447.
25. Toniolo, P.; Van Kappel, A. L.; Akhmedkhanov, A.; Ferrari, P.; Kato, I.; Shore, R. E.; Riboli, E. Serum carotenoids and breast cancer. Am. J. Epidemio., 2001, 153 (12), 1142-1147.
26. Sato, R.; Helzlsouer, K. J.; Alberg, A. J.; Hoffman, S. C.; Norkus, E. P.; Comstock, G. W. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2002, 11 (5), 451-457.
27. Knekt, P.; Aromaa, A.; Maatela, J.; Aaran, R. K.; Nikkari, T.; Hakama, M.; Hakulinen, T.; Peto, R.; Teppo, L. Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am. J. Epidemio., 1990, 132 (5), 857-870.
28. Knekt, P.; Albanes, D.; Seppanen, R.; Aromaa, A.; Jarvinen, R.; Hyvonen, L.; Teppo, L.; Pukkala, E. Dietary fat and risk of breast cancer. Am. J. Clin. Nutr., 1990, 52 (5), 903-908.
29. Knekt, P.; Aromaa, A.; Maatela, J.; Alfthan, G.; Aaran, R. K.; Hakama, M.; Hakulinen, T.; Peto, R.; Teppo, L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst., 1990, 82 (10), 864-868.
30. Cui, Y.; Shikany, J. M.; Liu, S.; Shagufta, Y.; Rohan, T. E. Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am. J. Clin. Nutr., 2008, 87 (4), 1009-1018.
31. Nagel, G.; Linseisen, J.; van Gils, C. H.; Peeters, P. H.; Boutron-Ruault, M. C.; Clavel-Chapelon, F.; Romieu, I.; Tjonneland, A.; Olsen, A.; Roswall, N.; Witt, P. M.; Overvad, K.; Rohrmann, S.; Kaaks, R.; Drogan, D.; Boeing, H.; Trichopoulou, A.; Stratigakou, V.; Zylis, D.; Engeset, D.; Lund, E.; Skeie, G.; Berrino, F.; Grioni, S.; Mattiello, A.; Masala, G.; Tumino, R.; Zanetti, R.; Ros, M. M.; Bueno-de-Mesquita, H. B.; Ardanaz, E.; Sanchez, M. J.; Huerta, J. M.; Amiano, P.; Rodriguez, L.; Manjer, J.; Wirfalt, E.; Lenner, P.; Hallmans, G.; Spencer, E. A.; Key, T. J.; Bingham, S.; Khaw, K. T.; Rinaldi, S.; Slimani, N.; Boffetta, P.; Gallo, V.; Norat, T.; Riboli, E. Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res. Treat., 2010, 119 (3), 753-765.
32. Ferroni, P.; Della-Morte, D.; Palmirotta, R.; McClendon, M.; Testa, G.; Abete, P.; Rengo, F.; Rundek, T.; Guadagni, F.; Roselli, M. Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuvenation Res., 2011, 14 (3), 293-308.
33. Banhegyi, G. [Lycopene--a natural antioxidant]. Orvosi. Hetilap., 2005, 146 (31), 1621-1624.
34. Clarke, R.; Armitage, J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc. Drugs Ther., 2002, 16 (5), 411-415.
35. Heber, D.; Lu, Q. Y. Overview of mechanisms of action of lycopene. Exp. Biol. Med (Maywood)., 2002, 227 (10), 920-923.
36. Sies, H.; Stahl, W. Non-nutritive bioactive constituents of plants: lycopene, lutein and zeaxanthin. Int. J. Vitam. Nutr. Res., 2003, 73 (2), 95-100.
37. Velpandian, T.; Arora, B.; Senthilkumari, S.; Ravi, A. K.; Gayathri, C.; Azad, R.; Ghose, S. Regional variation in the levels of macular xanthophylls and carotenoids in dietary components: comparing North and South India. J. Nutr. Sci. Vitaminol (Tokyo)., 2010, 56 (6), 411-420.
38. Levy J, B. E., Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr. Cancer., 1995, 24 (3), 257-266.
39. Karas, M.; Amir, H.; Fishman, D.; Danilenko, M.; Segal, S.; Nahum, A.; Koifmann, A.; Giat, Y.; Levy, J.; Sharoni, Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer., 2000, 36 (1), 101-111.
40. Salman, H.; Bergman, M.; Djaldetti, M.; Bessler, H. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother., 2007, 61 (6), 366-369.
41. Chalabi, N.; Delort, L.; Le Corre, L.; Satih, S.; Bignon, Y. J.; Bernard-Gallon, D. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics., 2006, 7 (5), 663-672.
42. Molnar, J.; Gyemant, N.; Mucsi, I.; Molnar, A.; Szabo, M.; Kortvelyesi, T.; Varga, A.; Molnar, P.; Toth, G. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids. In Vivo, 2004, 18 (2), 237-244.
43. Zhang, L. X.; Cooney, R. V.; Bertram, J. S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis, 1991, 12 (11), 2109-2114.
44. Muto, Y.; Fujii, J.; Shidoji, Y.; Moriwaki, H.; Kawaguchi, T.; Noda, T. Growth retardation in human cervical dysplasia-derived cell lines by beta-carotene through down-regulation of epidermal growth factor receptor. Am. J. Clin. Nutr., 1995, 62 (6 Suppl), 1535S-1540S.
45. Bertram, J. S.; Pung, A.; Churley, M.; Kappock, T. J. t.; Wilkins, L. R.; Cooney, R. V. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis, 1991, 12 (4), 671-678.
46. Biesalski, H. K.; Schaffer, M. Comparative assessment of the activity of beta-carotene, retinoyl-beta-D-glucuronide and retinoic acid on growth and differentiation of a human promyelocytic leukemia cell line HL-60. Int. J. Vitam. Nutr. Res., 1997, 67 (5), 357-363.
47. Moselhy, S. S.; Al mslmani, M. A. Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a) benzanthracene in sprague dawely female rats. Mol. Cell Biochem., 2008, 319 (1-2), 175-180.
48. Nahum, A.; Hirsch, K.; Danilenko, M.; Watts, C. K.; Prall, O. W.; Levy, J.; Sharoni, Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene, 2001, 20 (26), 3428-3436.
49. Kelly, G. S. Quercetin. Monograph. Altern. Med. Rev., 2011, 16 (2), 172-194.
50. Bors W H. W., Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol., 1990, 185 (343-55).
51. Prior, R. L. Fruits and vegetables in the prevention of cellular oxidative damage. Am. J. Clin. Nutr., 2003, 78 (3 Suppl), 570S-578S.
52. Day, A. J.; Bao, Y.; Morgan, M. R.; Williamson, G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med., 2000, 29 (12), 1234-1243.
53. Lamson, D. W.; Brignall, M. S. Antioxidants and cancer, part 3: quercetin. Altern. Med. Rev., 2000, 5 (3), 196-208.
54. Cheng S G. N., Zhang Z, Chen G, Budhraja A, Ke Z, Son YO, Wang X, Luo J, Shi X. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin. Cancer Res., 2010, 16 (23), 5676-5691.
55. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett., 2008, 269 (2), 315-325.
56. Nair, M. P.; Mahajan, S.; Reynolds, J. L.; Aalinkeel, R.; Nair, H.; Schwartz, S. A.; Kandaswami, C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin. Vaccine Immunol., 2006, 13 (3), 319-328.
57. Zhang, Q.; Zhao, X. H.; Wang, Z. J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol., 2008, 46 (6), 2042-2053.
58. Chien SY W. Y., Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ, Chen DR. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum. Exp. Toxicol., 2009, 28 (8), 493-503.
59. Ferry, D. R.; Smith, A.; Malkhandi, J.; Fyfe, D. W.; deTakats, P. G.; Anderson, D.; Baker, J.; Kerr, D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res., 1996, 2 (4), 659-668.
60. Fujiki, H. Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol., 1999, 125 (11), 589-597.
61. Kazi, A.; Smith, D. M.; Daniel, K.; Zhong, S.; Gupta, P.; Bosley, M. E.; Dou, Q. P. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo, 2002, 16 (6), 397-403.
62. Baliga, M. S.; Meleth, S.; Katiyar, S. K. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasisspecific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res., 2005, 11 (5), 1918-1927.
63. Roy, A. M.; Baliga, M. S.; Katiyar, S. K. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol. Cancer The., 2005, 4 (1), 81-90.
64. Mittal, A.; Pate, M. S.; Wylie, R. C.; Tollefsbol, T. O.; Katiyar, S. K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol., 2004, 24 (3), 703-710.
65. Yeh, C. W.; Chen, W. J.; Chiang, C. T.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J., 2003, 3 (5), 267-276.
66. Deguchi, H.; Fujii, T.; Nakagawa, S.; Koga, T.; Shirouzu, K. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D. Int. J. Oncol., 2002, 21 (6), 1301-1305.
67. Sartippour, M. R.; Shao, Z. M.; Heber, D.; Beatty, P.; Zhang, L.; Liu, C.; Ellis, L.; Liu, W.; Go, V. L.; Brooks, M. N. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr., 2002, 132 (8), 2307-2311.
68. Pianetti, S.; Guo, S.; Kavanagh, K. T.; Sonenshein, G. E. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res., 2002, 62 (3), 652-655.
69. Ozbay, T.; Nahta, R. Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines. Breast Cancer (Auckl)., 2011, 5, 143-154.
70. Syed, D. N.; Afaq, F.; Sarfaraz, S.; Khan, N.; Kedlaya, R.; Setaluri, V.; Mukhtar, H. Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation. Toxicol. Appl. Pharmacol., 2008, 231 (1), 52-60.
71. Singletary, K. W.; Jung, K. J.; Giusti, M. Anthocyanin-rich grape extract blocks breast cell DNA damage. J. Med. Food., 2007, 10 (2), 244-251.
72. Zhang, Y.; Vareed, S. K.; Nair, M. G. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life sciences, 2005, 76 (13), 1465-1472.
73. Seeram, N. P.; Zhang, Y.; Nair, M. G. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr. Cancer., 2003, 46 (1), 101-106.
74. Afaq, F.; Zaman, N.; Khan, N.; Syed, D. N.; Sarfaraz, S.; Zaid, M. A.; Mukhtar, H. Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables. Int. J. Cancer., 2008, 123 (7), 1508-1515.
75. Bouker, K. B.; Hilakivi-Clarke, L. Genistein: does it prevent or promote breast cancer? Environ. Health Perspect., 2000, 108 (8), 701-708.
76. Cappelletti, V.; Fioravanti, L.; Miodini, P.; Di Fronzo, G. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J. Cell Biochem., 2000, 79 (4), 594-600.
77. Chen, W. F.; Huang, M. H.; Tzang, C. H.; Yang, M.; Wong, M. S. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim. Biophys. Acta., 2003, 1638 (2), 187-196.
78. Chen, W. F.; Wong, M. S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab., 2004, 89 (5), 2351-2359.
79. Chinni, S. R.; Alhasan, S. A.; Multani, A. S.; Pathak, S.; Sarkar, F. H. Pleotropic effects of genistein on MCF-7 breast cancer cells. Int. J. Mol. Med., 2003, 12 (1), 29-34.
80. Constantinou, A. I.; Kamath, N.; Murley, J. S. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer., 1998, 34 (12), 1927-1934.
81. Fan, S.; Meng, Q.; Auborn, K.; Carter, T.; Rosen, E. M. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br. J. Cancer., 2006, 94 (3), 407-426.
82. Katdare, M.; Osborne, M.; Telang, N. T. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int. J. Oncol., 2002, 21 (4), 809-815.
83. Pugazhendhi, D.; Watson, K. A.; Mills, S.; Botting, N.; Pope, G. S.; Darbre, P. D. Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells. J. Endocrinol., 2008, 197 (3), 503-515.
84. Privat, M.; Aubel, C.; Arnould, S.; Communal, Y.; Ferrara, M.; Bignon, Y. J. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines. Anticancer Res.,2010, 30 (6), 2049-2054.
85. Peng, J. H.; Zhu, J. D.; Mi, M. T.; Li, F. J.; Cai, L.; Dong, J. Z.; Zhang, H. X.; Zhao, Y.; Xue, R. L. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur. J. Cancer Prev., 2010, 19 (2), 110-119.
86. Waite, K. A.; Sinden, M. R.; Eng, C. Phytoestrogen exposure elevates PTEN levels. Hum. Mol. Genet., 2005, 14 (11), 1457-1463.
87. Gong, L.; Li, Y.; Nedeljkovic-Kurepa, A.; Sarkar, F. H. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene, 2003, 22 (30), 4702-4709.
88. Li, Z.; Liu, W.; Mo, B.; Hu, C.; Liu, H.; Qi, H.; Wang, X.; Xu, J. Caffeine overcomes genistein-induced G2/M cell cycle arrest in breast cancer cells. Nutr. Cancer., 2008, 60 (3), 382-388.
89. Li, Z.; Li, J.; Mo, B.; Hu, C.; Liu, H.; Qi, H.; Wang, X.; Xu, J. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol. Toxicol., 2008, 24 (5), 401-409.
90. Lian, F.; Bhuiyan, M.; Li, Y. W.; Wall, N.; Kraut, M.; Sarkar, F. H. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr. Cancer., 1998, 31 (3), 184-191.
91. Choi, Y. H.; Zhang, L.; Lee, W. H.; Park, K. Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol., 1998, 13 (2), 391-396.
92. Pagliacci, M. C.; Smacchia, M.; Migliorati, G.; Grignani, F.; Riccardi, C.; Nicoletti, I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer., 1994, 30A (11), 1675-1682.
93. Pagliacci, M. C.; Spinozzi, F.; Migliorati, G.; Fumi, G.; Smacchia, M.; Grignani, F.; Riccardi, C.; Nicoletti, I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer., 1993, 29A (11), 1573-1577.
94. Privat, M.; Aubel, C.; Arnould, S.; Communal, Y.; Ferrara, M.; Bignon, Y. J. Breast cancer cell response to genistein is conditioned by BRCA1 mutations. Biochem. Biophys. Res. Commun., 2009, 379 (3), 785-789.
95. Tominaga, Y.; Wang, A.; Wang, R. H.; Wang, X.; Cao, L.; Deng, C. X. Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Cell Death Differ., 2007, 14 (3), 472-479.
96. Cabanes, A.; Wang, M.; Olivo, S.; DeAssis, S.; Gustafsson, J. A.; Khan, G.; Hilakivi-Clarke, L. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis, 2004, 25 (5), 741-748.
97. Bernard-Gallon, D. J.; Maurizis, J. C.; Rio, P. G.; Bignon, Y. J. Influence of genistein and daidzein on Brca1 protein levels in human breast cell lines. J. Natl. Cancer Inst., 1998, 90 (11), 862-863.
98. Vissac-Sabatier, C.; Coxam, V.; Dechelotte, P.; Picherit, C.; Horcajada, M. N.; Davicco, M. J.; Lebecque, P.; Bignon, Y. J.; Bernard-Gallon, D. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res.,2003, 63 (20), 6607-6612.
99. Yu, X.; Zhu, J.; Mi, M.; Chen, W.; Pan, Q.; Wei, M. Antiangiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med. Oncol., 2012, 29 (1), 349-357.
100. Murphy, K. J.; Chronopoulos, A. K.; Singh, I.; Francis, M. A.; Moriarty, H.; Pike, M. J.; Turner, A. H.; Mann, N. J.; Sinclair, A. J. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am. J. Clin. Nutr., 2003, 77 (6), 1466-1473.
101. Ye, X.; Krohn, R. L.; Liu, W.; Joshi, S. S.; Kuszynski, C. A.; McGinn, T. R.; Bagchi, M.; Preuss, H. G.; Stohs, S. J.; Bagchi, D. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol. Cell Biochem., 1999, 196 (1-2), 99-108.
102. Song, X.; Siriwardhana, N.; Rathore, K.; Lin, D.; Wang, H. C. Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Mol. Carcinog.,2010, 49 (5), 450-463.
103. Wen, W.; Lu, J.; Zhang, K.; Chen, S. Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev. Res (Phila)., 2008, 1 (7), 554-561.
104. Bhatia, N.; Zhao, J.; Wolf, D. M.; Agarwal, R. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer Lett., 1999, 147 (1-2), 77-84.
105. Wang, H. J.; Wei, X. F.; Jiang, Y. Y.; Huang, H.; Yang, Y.; Fan, S. M.; Zang, L. H.; Tashiro, S.; Onodera, S.; Ikejima, T. Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells. Free Radic. Res., 2010, 44 (5), 577-584.
106. Wang, H. J.; Jiang, Y. Y.; Wei, X. F.; Huang, H.; Tashiro, S.; Onodera, S.; Ikejima, T. Silibinin induces protective superoxide generation in human breast cancer MCF-7 cell. Free Radic. Res., 2010, 44 (1), 90-100.
107. Kim, S.; Choi, J. H.; Lim, H. I.; Lee, S. K.; Kim, W. W.; Kim, J. S.; Kim, J. H.; Choe, J. H.; Yang, J. H.; Nam, S. J.; Lee, J. E. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. Phytomedicine, 2009, 16 (6-7), 573-580.
108. Kim, S.; Han, J.; Kim, J. S.; Kim, J. H.; Choe, J. H.; Yang, J. H.; Nam, S. J.; Lee, J. E. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Anticancer Res., 2011, 31 (11), 3767-3773.
109. Kim, S.; Kim, S. H.; Hur, S. M.; Lee, S. K.; Kim, W. W.; Kim, J. S.; Kim, J. H.; Choe, J. H.; Nam, S. J.; Lee, J. E.; Yang, J. H. Silibinin prevents TPA-induced MMP-9 expression by downregulation of COX-2 in human breast cancer cells. J. Ethnopharmacol.,2009, 126 (2), 252-257.
110. Lee, S. O.; Jeong, Y. J.; Im, H. G.; Kim, C. H.; Chang, Y. C.; Lee, I. S. Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun., 2007, 354 (1), 165-171.
111. Tiwari, P.; Kumar, A.; Balakrishnan, S.; Kushwaha, H. S.; Mishra, K. P. Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest., 2011, 29 (1), 12-20.
112. Holy, J. M. Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat. Res.,2002, 518 (1), 71-84.
113. Ramsewak, R. S.; DeWitt, D. L.; Nair, M. G. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine,2000, 7 (4), 303-308.
114. Sen, G. S.; Mohanty, S.; Hossain, D. M.; Bhattacharyya, S.; Banerjee, S.; Chakraborty, J.; Saha, S.; Ray, P.; Bhattacharjee, P.; Mandal, D.; Bhattacharya, A.; Chattopadhyay, S.; Das, T.; Sa, G. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFkappaB-p300 cross-talk in favor of p53-p300 in breast cancer. J. Biol. Chem., 2011, 286 (49), 42232-42247.
115. Sun, A.; Lu, Y. J.; Hu, H.; Shoji, M.; Liotta, D. C.; Snyder, J. P. Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. Bioorg. Med. Chem. Lett., 2009, 19 (23), 6627-6631.
116. Yodkeeree, S.; Ampasavate, C.; Sung, B.; Aggarwal, B. B.; Limtrakul, P. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur. J. Pharmacol., 2010, 627 (1-3), 8-15.
117. Zhang, H. G.; Kim, H.; Liu, C.; Yu, S.; Wang, J.; Grizzle, W. E.; Kimberly, R. P.; Barnes, S. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim. Biophys. Acta., 2007, 1773 (7), 1116-1123.
118. Carroll, C. E.; Benakanakere, I.; Besch-Williford, C.; Ellersieck, M. R.; Hyder, S. M. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthraceneinduced mammary tumors. Menopause, 2010, 17 (1), 178-184.
119. Singletary, K.; MacDonald, C.; Iovinelli, M.; Fisher, C.; Wallig, M. Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene. Carcinogenesis,1998, 19 (6), 1039-1043.
120. Cutler, W. B. Re: Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cell. Menopause, 2008, 15 (6), 1195.
121. Chakraborty, G.; Jain, S.; Kale, S.; Raja, R.; Kumar, S.; Mishra, R.; Kundu, G. C. Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Mol. Med. Report., 2008, 1 (5), 641-646.
122. Carroll, C. E.; Ellersieck, M. R.; Hyder, S. M. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells. Menopause, 2008, 15 (3), 570-574.
123. Liu, Q.; Loo, W. T.; Sze, S. C.; Tong, Y. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine, 2009, 16 (10), 916-922.
124. Aggarwal, B. B.; Banerjee, S.; Bharadwaj, U.; Sung, B.; Shishodia, S.; Sethi, G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem. Pharmacol., 2007, 73 (7), 1024-1032.
125. Choudhuri, T.; Pal, S.; Das, T.; Sa, G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem., 2005, 280 (20), 20059-20068.
126. Kang, H. J.; Lee, S. H.; Price, J. E.; Kim, L. S. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J., 2009, 15 (3), 223-229.
127. Yoon, H.; Liu, R. H. Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. J. Agric. Food Chem., 2007, 55 (8), 3167-3173.
128. Lee, K. W.; Kim, J. H.; Lee, H. J.; Surh, Y. J. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid. Redox Signal., 2005, 7 (11-12), 1612-1620.
129. Aggarwal, B. B.; Shishodia, S.; Takada, Y.; Banerjee, S.; Newman, R. A.; Bueso-Ramos, C. E.; Price, J. E. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res., 2005, 11 (20), 7490-7498.
130. Bayet-Robert, M.; Kwiatkowski, F.; Leheurteur, M.; Gachon, F.; Planchat, E.; Abrial, C.; Mouret-Reynier, M. A.; Durando, X.; Barthomeuf, C.; Chollet, P. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol. Ther., 2010, 9 (1), 8-14.
131. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res., 2001, 21 (4B), 2895-2900.
132. Lee, H. S.; Seo, E. Y.; Kang, N. E.; Kim, W. K. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem., 2008, 19 (5), 313-319.
133. Ling, H.; Yang, H.; Tan, S. H.; Chui, W. K.; Chew, E. H. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kappaB activation. Br. J. Pharmacol., 2010, 161 (8), 1763-1777.
134. Hsu, Y. L.; Chen, C. Y.; Lin, I. P.; Tsai, E. M.; Kuo, P. L.; Hou, M. F. 4-Shogaol, an Active Constituent of Dietary Ginger, Inhibits Metastasis of MDA-MB-231 Human Breast Adenocarcinoma Cells by Decreasing the Repression of NF-kappaB/Snail on RKIP. J. Agric. Food Chem., 2012, 60 (3), 852-861.
135. Thoennissen, N. H.; O'Kelly, J.; Lu, D.; Iwanski, G. B.; La, D. T.; Abbassi, S.; Leiter, A.; Karlan, B.; Mehta, R.; Koeffler, H. P. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene, 2010, 29 (2), 285-296.
136. Lee, M. J.; Kee, K. H.; Suh, C. H.; Lim, S. C.; Oh, S. H. Capsaicininduced apoptosis is regulated by endoplasmic reticulum stressand calpain-mediated mitochondrial cell death pathways. Toxicol., 2009, 264 (3), 205-214.
137. Chang, H. C.; Chen, S. T.; Chien, S. Y.; Kuo, S. J.; Tsai, H. T.; Chen, D. R. Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum. Exp. Toxicol.,2011, 30 (10), 1657-1665.
138. Tasker, J. G.; Theodosis, D. T.; Poulain, D. A. The effects of neonatal capsaicin treatment on the sensory innervation of the nipple and on the milk ejection reflex in the rat. Exp. Brain Res.,1988, 73 (1), 32-38.
139. Morre, D. J.; Chueh, P. J.; Morre, D. M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. U. S. A., 1995, 92 (6), 1831-1835.
140. Kim, S.; Moon, A. Capsaicin-induced apoptosis of H-rastransformed human breast epithelial cells is Rac-dependent via ROS generation. Arch.Pharm. Res., 2004, 27 (8), 845-849.
141. Kang, H. J.; Soh, Y.; Kim, M. S.; Lee, E. J.; Surh, Y. J.; Kim, H. R.; Kim, S. H.; Moon, A. Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int. J. Cancer., 2003, 103 (4), 475-482.
142. Javorkova, N.; Hajtmanova, E.; Kostkova, L.; Zamecnik, L.; Pecova, R.; Hanacek, J.; Tatar, M. Changes of cough reflex sensitivity induced by cancer radiotherapy of chest and neck regions. J. Physiol. Pharmacol., 2006, 57 Suppl 4, 157-163.
143. Chou, C. C.; Wu, Y. C.; Wang, Y. F.; Chou, M. J.; Kuo, S. J.; Chen, D. R. Capsaicin-induced apoptosis in human breast cancer MCF-7 cells through caspase-independent pathway. Oncol. Rep., 2009, 21 (3), 665-671.
144. Alosi, J. A.; McDonald, D. E.; Schneider, J. S.; Privette, A. R.; McFadden, D. W. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspasedependent apoptosis. J. Surg. Res., 2010, 161 (2), 195-201.
145. Ergun, O.; Ergun, G.; Oktem, G.; Selvi, N.; Dogan, H.; Tuncyurek, M.; Saydam, G.; Erdener, A. Enteral resveratrol supplementation attenuates intestinal epithelial inducible nitric oxide synthase activity and mucosal damage in experimental necrotizing enterocolitis. J. Pediatr. Surg., 2007, 42 (10), 1687-1694.
146. Siddiqui, M. A.; Saquib, Q.; Ahamed, M.; Ahmad, J.; Al-Khedhairy, A. A.; Abou-Tarboush, F. M.; Musarrat, J. Effect of Trans-resveratrol on Rotenone-induced Cytotoxicity in Human Breast Adenocarcinoma Cells. Toxicol. Int., 2011, 18 (2), 105-110.
147. Le Corre, L.; Chalabi, N.; Delort, L.; Bignon, Y. J.; Bernard-Gallon, D. J. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res., 2005, 49 (5), 462-471.
148. Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J. M.; Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 1998, 273 (34), 21875-21882.
149. Subbaramaiah, K.; Michaluart, P.; Chung, W. J.; Tanabe, T.; Telang, N.; Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann. N. Y. Acad. Sci., 1999, 889, 214-223.
150. Azios, N. G.; Dharmawardhane, S. F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia, 2005, 7 (2), 128-140.
151. Tang, F. Y.; Su, Y. C.; Chen, N. C.; Hsieh, H. S.; Chen, K. S. Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol. Nutr. Food Res., 2008, 52 (6), 683-691.
152. Aiyar, S. E.; Park, H.; Aldo, P. B.; Mor, G.; Gildea, J. J.; Miller, A. L.; Thompson, E. B.; Castle, J. D.; Kim, S.; Santen, R. J. TMS, a chemically modified herbal derivative of resveratrol, induces cell death by targeting Bax. Breast Cancer Res. Treat., 2010, 124 (1), 265-277.
153. Filomeni, G.; Graziani, I.; Rotilio, G.; Ciriolo, M. R. trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr., 2007, 2 (3), 295-305.
154. Singh, N.; Nigam, M.; Ranjan, V.; Sharma, R.; Balapure, A. K.; Rath, S. K. Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells. J. Pharmacol. Sci., 2009, 109 (4), 473-485.
155. Alkhalaf, M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur. J. Cancer Prev., 2007, 16 (4), 334-341.
156. He, X.; Wang, Y.; Zhu, J.; Orloff, M.; Eng, C. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett., 2011, 301 (2), 168-176.
157. Tang, F. Y.; Chiang, E. P.; Sun, Y. C. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J. Nutr. Biochem., 2008, 19 (5), 287-294.
158. Bishayee, A.; Dhir, N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem. Biol. Interact., 2009, 179 (2-3), 131-144.
159. Lanzilli, G.; Fuggetta, M. P.; Tricarico, M.; Cottarelli, A.; Serafino, A.; Falchetti, R.; Ravagnan, G.; Turriziani, M.; Adamo, R.; Franzese, O.; Bonmassar, E. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int. J. Oncol., 2006, 28 (3), 641-648.
160. Li, Y.; Liu, J.; Liu, X.; Xing, K.; Wang, Y.; Li, F.; Yao, L. Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl. Biochem. Biotechnol., 2006, 135 (3), 181-192.
161. Fornier, M. N.; Rathkopf, D.; Shah, M.; Patil, S.; O'Reilly, E.; Tse, A. N.; Hudis, C.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K. Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Clin. Cancer Res., 2007, 13 (19), 5841-5846.
162. Tan, A. R.; Yang, X.; Berman, A.; Zhai, S.; Sparreboom, A.; Parr, A. L.; Chow, C.; Brahim, J. S.; Steinberg, S. M.; Figg, W. D.; Swain, S. M. Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer. Clin. Cancer Res., 2004, 10 (15), 5038-5047.
163. Nakanishi, T.; Karp, J. E.; Tan, M.; Doyle, L. A.; Peters, T.; Yang, W.; Wei, D.; Ross, D. D. Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients. Clin. Cancer Res., 2003, 9 (9), 3320-3328.
164. Wall, N. R.; O'Connor, D. S.; Plescia, J.; Pommier, Y.; Altieri, D. C. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res., 2003, 63 (1), 230-235.
165. Wu, K.; Wang, C.; D'Amico, M.; Lee, R. J.; Albanese, C.; Pestell, R. G.; Mani, S. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. Mol. Cancer Ther., 2002, 1 (9), 695-706.
166. Mayer, F.; Mueller, S.; Malenke, E.; Kuczyk, M.; Hartmann, J. T.; Bokemeyer, C. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines. Invest. New Drugs., 2005, 23 (3), 205-211.
167. Li, Y.; Bhuiyan, M.; Alhasan, S.; Senderowicz, A. M.; Sarkar, F. H. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. Clin. Cancer Res., 2000, 6 (1), 223-229.
168. Wang, L. M.; Ren, D. M. Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy. Mini Rev. Med. Chem., 2010, 10 (11), 1058-1070.
169. Grant, S.; Roberts, J. D. The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy. Drug Resist. Updat., 2003, 6 (1), 15-26.
170. Fandy, T. E.; Ross, D. D.; Gore, S. D.; Srivastava, R. K. Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL. Cancer Chemother. Pharmacol., 2007, 60 (3), 313-319.
171. Palacios, C.; Yerbes, R.; Lopez-Rivas, A. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells. Cancer Res., 2006, 66 (17), 8858-8869.
172. Lai, K. C.; Huang, A. C.; Hsu, S. C.; Kuo, C. L.; Yang, J. S.; Wu, S. H.; Chung, J. G. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J. Agric. Food Chem., 2010, 58 (5), 2935-2942.
173. Sharma, A.; Sharma, A. K.; Madhunapantula, S. V.; Desai, D.; Huh, S. J.; Mosca, P.; Amin, S.; Robertson, G. P. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clin. Cancer Res., 2009, 15 (5), 1674-1685.
174. Azarenko, O.; Okouneva, T.; Singletary, K. W.; Jordan, M. A.; Wilson, L. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Carcinogenesis,2008, 29 (12), 2360-2368.
175. Jakubikova, J.; Cervi, D.; Ooi, M.; Kim, K.; Nahar, S.; Klippel, S.; Cholujova, D.; Leiba, M.; Daley, J. F.; Delmore, J.; Negri, J.; Blotta, S.; McMillin, D. W.; Hideshima, T.; Richardson, P. G.; Sedlak, J.; Anderson, K. C.; Mitsiades, C. S. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica, 2011, 96 (8), 1170-1179.
176. Hwang, E. S.; Jeffery, E. H. Induction of quinone reductase by sulforaphane and sulforaphane N-acetylcysteine conjugate in murine hepatoma cells. J. Med. Food., 2005, 8 (2), 198-203.
177. Zhang, Y. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis, 2000, 21 (6), 1175-1182.
178. Prawan, A.; Saw, C. L.; Khor, T. O.; Keum, Y. S.; Yu, S.; Hu, L.; Kong, A. N. Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem. Biol. Interact., 2009, 179 (2-3), 202-211.
179. Mas, S.; Crescenti, A.; Gasso, P.; Deulofeu, R.; Molina, R.; Ballesta, A.; Kensler, T. W.; Lafuente, A. Induction of apoptosis in HT-29 cells by extracts from isothiocyanates-rich varieties of Brassica oleracea. Nutr. Cancer., 2007, 58 (1), 107-114.
180. Schindlbeck, C.; Janni, W.; Shabani, N.; Rack, B.; Gerber, B.; Schmitt, M.; Harbeck, N.; Sommer, H.; Braun, S.; Friese, K. Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow. Breast Cancer Res. Treat.,2004, 87 (1), 65-74.
181. Fowke, J. H.; Chung, F. L.; Jin, F.; Qi, D.; Cai, Q.; Conaway, C.; Cheng, J. R.; Shu, X. O.; Gao, Y. T.; Zheng, W. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res., 2003, 63 (14), 3980-3986.
182. Naume, B.; Borgen, E.; Kvalheim, G.; Karesen, R.; Qvist, H.; Sauer, T.; Kumar, T.; Nesland, J. M. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin. Cancer Res., 2001, 7 (12), 4122-4129.
183. Zhang, Y. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis, 2001, 22 (3), 425-431.
184. Kim, S. H.; Singh, S. V. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression. Cancer Prev. Res (Phila).,2010, 3 (6), 718-726.
185. Kim, S. H.; Nagalingam, A.; Saxena, N. K.; Singh, S. V.; Sharma, D. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis, 2011, 32 (3), 359-367.
186. Rose, P.; Huang, Q.; Ong, C. N.; Whiteman, M. Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol. Appl. Pharmacol., 2005, 209 (2), 105-113.
187. Hunakova, L.; Sedlakova, O.; Cholujova, D.; Gronesova, P.; Duraj, J.; Sedlak, J. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma, 2009, 56 (6), 548-556.
188. Ravizza, R.; Gariboldi, M. B.; Molteni, R.; Monti, E. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. Oncol. Rep., 2008, 20 (3), 625-630.
189. Stark, M. J.; Burke, Y. D.; McKinzie, J. H.; Ayoubi, A. S.; Crowell, P. L. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett., 1995, 96 (1), 15-21.
190. Chaudhary, S. C.; Alam, M. S.; Siddiqui, M. S.; Athar, M. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. Chem. Biol. Interact., 2009, 179 (2-3), 145-153.
191. Chung, B. H.; Lee, H. Y.; Lee, J. S.; Young, C. Y. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett., 2006, 236 (2), 222-228.
192. Loutrari, H.; Hatziapostolou, M.; Skouridou, V.; Papadimitriou, E.; Roussos, C.; Kolisis, F. N.; Papapetropoulos, A. Perillyl alcohol is an angiogenesis inhibitor. J. Pharmacol. Exp. Ther., 2004, 311 (2), 568-575.
193. Yuri, T.; Danbara, N.; Tsujita-Kyutoku, M.; Kiyozuka, Y.; Senzaki, H.; Shikata, N.; Kanzaki, H.; Tsubura, A. Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. Breast Cancer Res. Treat., 2004, 84 (3), 251-260.
194. Xu, M.; Floyd, H. S.; Greth, S. M.; Chang, W. C.; Lohman, K.; Stoyanova, R.; Kucera, G. L.; Kute, T. E.; Willingham, M. C.; Miller, M. S. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Toxicol. Appl. Pharmacol., 2004, 195 (2), 232-246.
195. Elegbede, J. A.; Flores, R.; Wang, R. C. Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. Life Sci.,2003, 73 (22), 2831-2840.
196. Unlu, S.; Mason, C. D.; Schachter, M.; Hughes, A. D. Perillyl alcohol, an inhibitor of geranylgeranyl transferase, induces apoptosis of immortalized human vascular smooth muscle cells in vitro. J. Cardiovasc. Pharmacol., 2000, 35 (2), 341-344.
197. Greenwald, P.; Kelloff, G. J.; Boone, C. W.; McDonald, S. S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev., 1995, 4 (7), 691-702.
198. Bardon, S.; Foussard, V.; Fournel, S.; Loubat, A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett., 2002, 181 (2), 187-194.
199. Yeruva, L.; Pierre, K. J.; Elegbede, A.; Wang, R. C.; Carper, S. W. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett., 2007, 257 (2), 216-226.
200. Clark, S. S. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells. Oncology, 2006, 70 (1), 13-18.
201. Haag, J. D.; Gould, M. N. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother. Pharmacol., 1994, 34 (6), 477-483.
202. Crowell, P. L. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr., 1999, 129 (3), 775S-778S.
203. Crowell, P. L. Monoterpenes in breast cancer chemoprevention. Breast Cancer Res. Treat.,1997, 46 (2-3), 191-197.
204. Berchtold, C. M.; Chen, K. S.; Miyamoto, S.; Gould, M. N. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factorkappaB pathway. Cancer Res., 2005, 65 (18), 8558-8566.
205. Ammon, H. P. Boswellic acids in chronic inflammatory diseases. Planta Med.,2006, 72 (12), 1100-1116.
206. Chashoo, G.; Singh, S. K.; Sharma, P. R.; Mondhe, D. M.; Hamid, A.; Saxena, A.; Andotra, S. S.; Shah, B. A.; Qazi, N. A.; Taneja, S. C.; Saxena, A. K. A propionyloxy derivative of 11-keto-betaboswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition. Chem. Biol. Interact., 2011, 189 (1-2), 60-71.
207. Hostanska, K.; Daum, G.; Saller, R. Cytostatic and apoptosisinducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res., 2002, 22 (5), 2853-2862.
208. Zhang, Y.; Duan, R. D. Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis., 2009, 8, 51.
209. Suhail, M. M.; Wu, W.; Cao, A.; Mondalek, F. G.; Fung, K. M.; Shih, P. T.; Fang, Y. T.; Woolley, C.; Young, G.; Lin, H. K. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern. Med., 2011, 11, 129.
210. He, X.; Liu, R. H. Cranberry phytochemicals: Isolation, structure elucidation, and their antiproliferative and antioxidant activities. J. Agric. Food Chem., 2006, 54 (19), 7069-7074.
211. Kassi, E.; Sourlingas, T. G.; Spiliotaki, M.; Papoutsi, Z.; Pratsinis, H.; Aligiannis, N.; Moutsatsou, P. Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest.,2009, 27 (7), 723-733.
212. Murphy, B. T.; MacKinnon, S. L.; Yan, X.; Hammond, G. B.; Vaisberg, A. J.; Neto, C. C. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J. Agric. Food Chem., 2003, 51 (12), 3541-3545.
213. Nangia-Makker, P.; Tait, L.; Shekhar, M. P.; Palomino, E.; Hogan, V.; Piechocki, M. P.; Funasaka, T.; Raz, A. Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum. Int. J. Cancer., 2007, 121 (4), 884-894.
214. Subbaramaiah, K.; Michaluart, P.; Sporn, M. B.; Dannenberg, A. J. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res.,2000, 60 (9), 2399-2404.
215. Zhang, G. P.; Lu, Y. Y.; Lv, J. C.; Ou, H. J. [Effect of ursolic acid on caspase-3 and PARP expression of human MCF-7 cells]. Zhongguo Zhong Yao Za Zhi., 2006, 31 (2), 141-144.
216. Yeh, C. T.; Wu, C. H.; Yen, G. C. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol. Nutr. Food Res., 2010, 54 (9), 1285-1295.
217. Wang, J. S.; Ren, T. N.; Xi, T. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med. Oncol.,2012, 29(1), 10-15.
218. Kanjoormana, M.; Kuttan, G. Antiangiogenic activity of ursolic acid. Integr. Cancer Ther., 2010, 9 (2), 224-235.
219. Lin, C. C.; Hsu, Y. F.; Lin, T. C. Antioxidant and free radical scavenging effects of the tannins of Terminalia catappa L. Anticancer Res., 2001, 21 (1A), 237-243.
220. Seeram, N. P.; Henning, S. M.; Zhang, Y.; Suchard, M.; Li, Z.; Heber, D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J. Nutr., 2006, 136 (10), 2481-2485.
221. Losso, J. N.; Bansode, R. R.; Trappey, A., 2nd; Bawadi, H. A.; Truax, R. In vitro anti-proliferative activities of ellagic acid. J. Nutr. Biochem., 2004, 15 (11), 672-678.
222. Kim, N. D.; Mehta, R.; Yu, W.; Neeman, I.; Livney, T.; Amichay, A.; Poirier, D.; Nicholls, P.; Kirby, A.; Jiang, W.; Mansel, R.; Ramachandran, C.; Rabi, T.; Kaplan, B.; Lansky, E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treat., 2002, 71 (3), 203-217.
223. Mehta, R.; Lansky, E. P. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur. J. Cancer Prev., 2004, 13 (4), 345-348.
224. Shukla, M.; Gupta, K.; Rasheed, Z.; Khan, K. A.; Haqqi, T. M. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. J. Inflamm. (Lond), 2008, 5, 9.
225. Jeune, M. A.; Kumi-Diaka, J.; Brown, J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J. Med. Food., 2005, 8 (4), 469-475.
226. Rumjahn, S. M.; Javed, M. A.; Wong, N.; Law, W. E.; Buxton, I. L. Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br. J. Cancer., 2007, 97 (10), 1372-1380.
227. Kapoor, S. Guggulsterone: a potent farnesoid X receptor antagonist and its rapidly evolving role as a systemic anticarcinogenic agent. Hepatology, 2008, 48 (6), 2090-2091.
228. Silva, J.; Dasgupta, S.; Wang, G.; Krishnamurthy, K.; Ritter, E.; Bieberich, E. Lipids isolated from bone induce the migration of human breast cancer cells. J. Lipid Res., 2006, 47 (4), 724-733.
229. Shishodia, S.; Sethi, G.; Ahn, K. S.; Aggarwal, B. B. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem. Pharmacol., 2007, 74 (1), 118-130.
230. Ichikawa, H.; Aggarwal, B. B. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin. Cancer Res.,2006, 12 (2), 662-668.
231. Reynolds, J. V.; Donohoe, C. L.; Doyle, S. L. Diet, obesity and cancer. Ir. J. Med. Sci., 2011, 180 (2), 521-527.
232. Wattenberg, L. W. Inhibition of carcinogenesis by minor anutrient constituents of the diet. The Proceedings of the Nutrition Society., 1990, 49 (2), 173-183.
233. Pinto, J. T.; Rivlin, R. S. Antiproliferative effects of allium derivatives from garlic. J. Nutr., 2001, 131 (3s), 1058S-1060S.
234. Gapter, L. A.; Yuin, O. Z.; Ng, K. Y. S-Allylcysteine reduces breast tumor cell adhesion and invasion. Biochem. Biophys. Res. Commun., 2008, 367 (2), 446-451.
235. Vogt, A.; Tamura, K.; Watson, S.; Lazo, J. S. Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1. J. Pharmacol. Exp. Ther., 2000, 294 (3), 1070-1075.
236. Malki, A.; El-Saadani, M.; Sultan, A. S. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol. Ther., 2009, 8 (22), 2175-2185.
237. Green, M.; Wilson, C.; Newell, O.; Sadrud-Din, S.; Thomas, R. Diallyl sulfide inhibits diethylstilbesterol-induced DNA adducts in the breast of female ACI rats. Food Chem. Toxicol., 2005, 43 (9), 1323-1331.
238. Lea, M.; Ayyala, U. Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells. Int. J. Oncol., 1997, 11 (1), 181-185.
239. Lea, M. A.; Randolph, V. M.; Patel, M. Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. Int. J. Oncol., 1999, 15 (2), 347-352.
240. Nakagawa, H.; Tsuta, K.; Kiuchi, K.; Senzaki, H.; Tanaka, K.; Hioki, K.; Tsubura, A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis., 2001, 22 (6), 891-897.
241. Tsubura, A.; Lai, Y. C.; Kuwata, M.; Uehara, N.; Yoshizawa, K. Anticancer effects of garlic and garlic-derived compounds for breast cancer control. Anticancer Agents Med. Chem., 2011, 11 (3), 249-253.
242. Lei, X. Y.; Yao, S. Q.; Zu, X. Y.; Huang, Z. X.; Liu, L. J.; Zhong, M.; Zhu, B. Y.; Tang, S. S.; Liao, D. F. Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-7. Acta Pharmacol. Sin., 2008, 29 (10), 1233-1239.
243. Kulkarni, S. K.; Dhir, A. Withania somnifera: an Indian ginseng. Prog. Neuropsychopharmacol. Biol. Psychiatry., 2008, 32 (5), 1093-1105.
244. Mishra, L. C.; Singh, B. B.; Dagenais, S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern. Med. Rev., 2000, 5 (4), 334-346.
245. Winters, M. Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern. Med. Rev., 2006, 11 (4), 269-277.
246. Zhang, X.; Samadi, A. K.; Roby, K. F.; Timmermann, B.; Cohen, M. S. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol. Oncol., 2012, 124(3)606-612.
247. Zhang, X.; Mukerji, R.; Samadi, A. K.; Cohen, M. S. Downregulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement Altern. Med., 2011, 11, 84.
248. Hahm, E. R.; Moura, M. B.; Kelley, E. E.; Van Houten, B.; Shiva, S.; Singh, S. V. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One.,2011, 6 (8), e23354.
249. Thaiparambil, J. T.; Bender, L.; Ganesh, T.; Kline, E.; Patel, P.; Liu, Y.; Tighiouart, M.; Vertino, P. M.; Harvey, R. D.; Garcia, A.; Marcus, A. I. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer., 2011, 129 (11), 2744-2755.
250. Wen, Z.; Wang, Z.; Wang, S.; Ravula, R.; Yang, L.; Xu, J.; Wang, C.; Zuo, Z.; Chow, M. S.; Shi, L.; Huang, Y. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One., 2011, 6 (3), e18278.
251. Hahm, E. R.; Lee, J.; Huang, Y.; Singh, S. V. Withaferin a suppresses estrogen receptor-alpha expression in human breast cancer cells. Mol. Carcinog., 2011, 50 (8), 614-624.
252. Yadav, V. R.; Sung, B.; Prasad, S.; Kannappan, R.; Cho, S. G.; Liu, M.; Chaturvedi, M. M.; Aggarwal, B. B. Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. J. Mol. Med (Berl)., 2010, 88 (12), 1243-1253.
253. Lee, J.; Hahm, E. R.; Singh, S. V. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis, 2010, 31 (11), 1991-1998.
254. Ndlovu, M. N.; Van Lint, C.; Van Wesemael, K.; Callebert, P.; Chalbos, D.; Haegeman, G.; Vanden Berghe, W. Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell Biol., 2009, 29 (20), 5488-5504.
255. Stan, S. D.; Zeng, Y.; Singh, S. V. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr. Cancer., 2008, 60 Suppl 1, 51-60.
256. Stan, S. D.; Hahm, E. R.; Warin, R.; Singh, S. V. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res., 2008, 68 (18), 7661-7669.
257. Ichikawa, H.; Takada, Y.; Shishodia, S.; Jayaprakasam, B.; Nair, M. G.; Aggarwal, B. B. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaBregulated gene expression. Mol. Cancer Ther., 2006, 5 (6), 1434-1445.
258. Kaileh, M.; Vanden Berghe, W.; Heyerick, A.; Horion, J.; Piette, J.; Libert, C.; De Keukeleire, D.; Essawi, T.; Haegeman, G. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J. Biol Chem., 2007, 282 (7), 4253-4264.
259. Koduru, S.; Kumar, R.; Srinivasan, S.; Evers, M. B.; Damodaran, C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol. Cancer Ther., 2010, 9 (1), 202-210.
260. Srinivasan, S.; Ranga, R. S.; Burikhanov, R.; Han, S. S.; Chendil, D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res., 2007, 67 (1), 246-253.
261. Ranga, R. S.; Girija, R.; Nur-e-Alam, M.; Sathishkumar, S.; Akbarsha, M. A.; Thirugnanam, S.; Rohr, J.; Ahmed, M. M.; Chendil, D. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer Chemother. Pharmacol., 2004, 54 (1), 7-15.
262. Yi, L. T.; Li, Y. C.; Pan, Y.; Li, J. M.; Xu, Q.; Mo, S. F.; Qiao, C. F.; Jiang, F. X.; Xu, H. X.; Lu, X. B.; Kong, L. D.; Kung, H. F. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea Corylifolia in the forced swimming test in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry., 2008, 32 (2), 510-519.
263. Shin, H. R. [Global activity of cancer registries and cancer control and cancer incidence statistics in Korea]. J. Prev. Med. Public Health., 2008, 41 (2), 84-91.
264. Kim, Y. C.; Oh, H.; Kim, B. S.; Kang, T. H.; Ko, E. K.; Han, Y. M.; Kim, B. Y.; Ahn, J. S. In vitro protein tyrosine phosphatase 1B inhibitory phenols from the seeds of Psoralea corylifolia. Planta Med., 2005, 71 (1), 87-89.
265. Mar, W.; Je, K. H.; Seo, E. K. Cytotoxic constituents of Psoralea corylifolia. Arch. Pharm. Res., 2001, 24 (3), 211-213.